{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T01:22:58Z","timestamp":1788744178456,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["K01MH112983"],"award-info":[{"award-number":["K01MH112983"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["F31MH119699"],"award-info":[{"award-number":["F31MH119699"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["F31MH113259"],"award-info":[{"award-number":["F31MH113259"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS112171"],"award-info":[{"award-number":["R01NS112171"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","award":["Young Investigator Award"],"award-info":[{"award-number":["Young Investigator Award"]}],"id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM007628-36"],"award-info":[{"award-number":["GM007628-36"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM007628-36"],"award-info":[{"award-number":["GM007628-36"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001819","name":"International Rett Syndrome Foundation","doi-asserted-by":"publisher","award":["3503"],"award-info":[{"award-number":["3503"]}],"id":[{"id":"10.13039\/100001819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001819","name":"International Rett Syndrome Foundation","doi-asserted-by":"publisher","award":["3903"],"award-info":[{"award-number":["3903"]}],"id":[{"id":"10.13039\/100001819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s13311-022-01254-3","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T11:10:14Z","timestamp":1654600214000},"page":"1340-1352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Clinical and Preclinical Evidence for M1 Muscarinic Acetylcholine Receptor Potentiation as a Therapeutic Approach for Rett Syndrome"],"prefix":"10.1016","volume":"19","author":[{"given":"Mackenzie","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bright","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Cikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calista","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl Anne D.","family":"Vermudez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W.","family":"Lindsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen M.","family":"Niswender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0254-7643","authenticated-orcid":false,"given":"Rocco G.","family":"Gogliotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1007\/s13311-022-01254-3_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat Genet"},{"issue":"5880","key":"10.1007\/s13311-022-01254-3_bib2","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1126\/science.1153252","article-title":"MeCP2, a key contributor to neurological disease, activates and represses transcription","volume":"320","author":"Chahrour","year":"2008","journal-title":"Science"},{"issue":"7","key":"10.1007\/s13311-022-01254-3_bib3","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/nn.3434","article-title":"Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR\/SMRT co-repressor","volume":"16","author":"Lyst","year":"2013","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1007\/s13311-022-01254-3_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13073-017-0411-7","article-title":"MeCP2 mutations: progress towards understanding and treating Rett syndrome","volume":"9","author":"Shah","year":"2017","journal-title":"Genome Med"},{"issue":"6","key":"10.1007\/s13311-022-01254-3_bib5","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/01.mop.0000143693.59408.ce","article-title":"Rett syndrome: clinical and molecular update","volume":"16","author":"Percy","year":"2004","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"10.1007\/s13311-022-01254-3_bib6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00019052-199504000-00013","article-title":"Rett syndrome","volume":"8","author":"Percy","year":"1995","journal-title":"Curr Opin Neurol"},{"key":"10.1007\/s13311-022-01254-3_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neures.2016.11.003","article-title":"Valley of death: A proposal to build a \"translational bridge\" for the next generation","volume":"115","author":"Gamo","year":"2017","journal-title":"Neurosci Res"},{"issue":"2","key":"10.1007\/s13311-022-01254-3_bib8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1124\/jpet.117.246991","article-title":"Total RNA sequencing of Rett syndrome autopsy samples identifies the M4 muscarinic receptor as a novel therapeutic target","volume":"365","author":"Gogliotti","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-022-01254-3_bib9","doi-asserted-by":"crossref","unstructured":"Gogliotti RG, Senter RK, Fisher NM, Adams J, Zamorano R, Walker AG, et al. mGlu7 potentiation rescues cognitive, social, and respiratory phenotypes in a mouse model of Rett syndrome. Sci Transl Med. 2017;9(403).","DOI":"10.1126\/scitranslmed.aai7459"},{"issue":"1","key":"10.1007\/s13311-022-01254-3_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0306-4522(96)00019-X","article-title":"Choline acetyltransferase activity and vesamicol binding in Rett syndrome and in rats with nucleus basalis lesions","volume":"73","author":"Wenk","year":"1996","journal-title":"Neuroscience"},{"issue":"2","key":"10.1007\/s13311-022-01254-3_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-2007-979740","article-title":"Neurobiology of Rett syndrome","volume":"26","author":"Johnston","year":"1995","journal-title":"Neuropediatrics"},{"issue":"10","key":"10.1007\/s13311-022-01254-3_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258830","article-title":"Substantial acetylcholine reduction in multiple brain regions of Mecp2-deficient female rats and associated behavioral abnormalities","volume":"16","author":"Murasawa","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1007\/s13311-022-01254-3_bib13","doi-asserted-by":"crossref","unstructured":"Ballinger EC, Schaaf CP, Patel AJ, de Maio A, Tao H, Talmage DA, et al. Mecp2 deletion from cholinergic neurons selectively impairs recognition memory and disrupts cholinergic modulation of the perirhinal cortex. eNeuro. 2019;6(6).","DOI":"10.1523\/ENEURO.0134-19.2019"},{"issue":"10","key":"10.1007\/s13311-022-01254-3_bib14","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/jnr.23760","article-title":"An optogenetic mouse model of rett syndrome targeting on catecholaminergic neurons","volume":"94","author":"Zhang","year":"2016","journal-title":"J Neurosci Res"},{"key":"10.1007\/s13311-022-01254-3_bib15","doi-asserted-by":"crossref","unstructured":"Zhang Y, Zhu Y, Cao SX, Sun P, Yang JM, Xia YF, et al. MeCP2 in cholinergic interneurons of nucleus accumbens regulates fear learning. Elife. 2020;9.","DOI":"10.7554\/eLife.55342"},{"issue":"2","key":"10.1007\/s13311-022-01254-3_bib16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.nbd.2007.02.003","article-title":"Postnatal dietary choline supplementation alters behavior in a mouse model of Rett syndrome","volume":"26","author":"Nag","year":"2007","journal-title":"Neurobiol Dis"},{"issue":"4","key":"10.1007\/s13311-022-01254-3_bib17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archneur.1997.00550160091022","article-title":"Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease","volume":"54","author":"Bodick","year":"1997","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1007\/s13311-022-01254-3_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00177553","article-title":"The effects of scopolamine on working memory in healthy young volunteers","volume":"96","author":"Rusted","year":"1988","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1007\/s13311-022-01254-3_bib19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa2017015","article-title":"Muscarinic cholinergic receptor agonist and peripheral antagonist for schizophrenia","volume":"384","author":"Brannan","year":"2021","journal-title":"N Engl J Med"},{"issue":"34","key":"10.1007\/s13311-022-01254-3_bib20","doi-asserted-by":"crossref","first-page":"13612","DOI":"10.1523\/JNEUROSCI.1854-13.2013","article-title":"Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome","volume":"33","author":"Garg","year":"2013","journal-title":"J Neurosci"},{"issue":"1","key":"10.1007\/s13311-022-01254-3_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/hmg\/dds406","article-title":"Female Mecp2(+\/-) mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies","volume":"22","author":"Samaco","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1007\/s13311-022-01254-3_bib22","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.neuroscience.2007.02.009","article-title":"Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome","volume":"146","author":"Stearns","year":"2007","journal-title":"Neuroscience"},{"issue":"4","key":"10.1007\/s13311-022-01254-3_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tips.2019.02.007","article-title":"A coordinated attack: Rett syndrome therapeutic development","volume":"40","author":"Gogliotti","year":"2019","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"10.1007\/s13311-022-01254-3_bib24","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/npp.2015.189","article-title":"Potentiation of M1 muscarinic receptor reverses plasticity deficits and negative and cognitive symptoms in a schizophrenia mouse model","volume":"41","author":"Ghoshal","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1007\/s13311-022-01254-3_bib25","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/nprot.2013.155","article-title":"Object recognition test in mice","volume":"8","author":"Leger","year":"2013","journal-title":"Nat Protoc"},{"issue":"4","key":"10.1007\/s13311-022-01254-3_bib26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00210-008-0365-9","article-title":"Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice","volume":"379","author":"Jositsch","year":"2009","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1007\/s13311-022-01254-3_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mcn.2014.01.005","article-title":"MeCP2 is required for activity-dependent refinement of olfactory circuits","volume":"59","author":"Degano","year":"2014","journal-title":"Mol Cell Neurosci"},{"issue":"6","key":"10.1007\/s13311-022-01254-3_bib28","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.neuron.2012.12.004","article-title":"NMDA receptor regulation prevents regression of visual cortical function in the absence of Mecp2","volume":"76","author":"Durand","year":"2012","journal-title":"Neuron"},{"issue":"34","key":"10.1007\/s13311-022-01254-3_bib29","doi-asserted-by":"crossref","first-page":"E4782","DOI":"10.1073\/pnas.1506499112","article-title":"MeCP2 regulates the timing of critical period plasticity that shapes functional connectivity in primary visual cortex","volume":"112","author":"Krishnan","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"10.1007\/s13311-022-01254-3_bib30","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1002\/cne.24315","article-title":"Structural and functional differences in the barrel cortex of Mecp2 null mice","volume":"525","author":"Lee","year":"2017","journal-title":"J Comp Neurol"},{"issue":"2","key":"10.1007\/s13311-022-01254-3_bib31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2016.05.033","article-title":"Peripheral mechanosensory neuron dysfunction underlies tactile and behavioral deficits in mouse models of ASDs","volume":"166","author":"Orefice","year":"2016","journal-title":"Cell"},{"issue":"8","key":"10.1007\/s13311-022-01254-3_bib32","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0165-6147(93)90049-P","article-title":"Molecular basis of muscarinic acetylcholine receptor function","volume":"14","author":"Wess","year":"1993","journal-title":"Trends Pharmacol Sci"},{"issue":"11","key":"10.1007\/s13311-022-01254-3_bib33","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/nn.4347","article-title":"Histone deacetylase 3 associates with MeCP2 to regulate FOXO and social behavior","volume":"19","author":"Nott","year":"2016","journal-title":"Nat Neurosci"},{"issue":"4","key":"10.1007\/s13311-022-01254-3_bib34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10606820308263","article-title":"Cellular signaling mechanisms for muscarinic acetylcholine receptors","volume":"9","author":"Lanzafame","year":"2003","journal-title":"Recept Channels"},{"issue":"8","key":"10.1007\/s13311-022-01254-3_bib35","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.1111\/ejn.14841","article-title":"GSK-3beta regulates the synaptic expression of NMDA receptors via phosphorylation of phosphatidylinositol 4 kinase type IIalpha","volume":"54","author":"Amici","year":"2021","journal-title":"Eur J Neurosci"},{"issue":"6","key":"10.1007\/s13311-022-01254-3_bib36","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.celrep.2018.04.010","article-title":"Inhibition of Gsk3b reduces Nfkb1 signaling and rescues synaptic activity to improve the Rett syndrome phenotype in Mecp2-knockout mice","volume":"23","author":"Jorge-Torres","year":"2018","journal-title":"Cell Rep"},{"issue":"6","key":"10.1007\/s13311-022-01254-3_bib37","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1242\/dmm.011007","article-title":"Preclinical research in Rett syndrome: setting the foundation for translational success","volume":"5","author":"Katz","year":"2012","journal-title":"Dis Model Mech"},{"key":"10.1007\/s13311-022-01254-3_bib38","doi-asserted-by":"crossref","unstructured":"Tillotson R, Bird A. The molecular basis of MeCP2 function in the brain. J Mol Biol. 2019.","DOI":"10.1016\/j.jmb.2019.10.004"},{"key":"10.1007\/s13311-022-01254-3_bib39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.trci.2018.03.004","article-title":"Randomized, controlled, proof-of-concept trial of MK-7622 in Alzheimer's disease","volume":"4","author":"Voss","year":"2018","journal-title":"Alzheimers Dement (N Y)"},{"issue":"9","key":"10.1007\/s13311-022-01254-3_bib40","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1021\/acschemneuro.8b00106","article-title":"PF-06827443 displays robust allosteric agonist and positive allosteric modulator activity in high receptor reserve and native systems","volume":"9","author":"Moran","year":"2018","journal-title":"ACS Chem Neurosci"},{"issue":"8","key":"10.1007\/s13311-022-01254-3_bib41","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/s41386-018-0033-9","article-title":"M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition","volume":"43","author":"Moran","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1007\/s13311-022-01254-3_bib42","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1021\/acschemneuro.8b00131","article-title":"A novel M1 PAM VU0486846 exerts efficacy in cognition models without displaying agonist activity or cholinergic toxicity","volume":"9","author":"Rook","year":"2018","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"10.1007\/s13311-022-01254-3_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.560","article-title":"T-495, a novel low cooperative M1 receptor positive allosteric modulator, improves memory deficits associated with cholinergic dysfunction and is characterized by low gastrointestinal side effect risk","volume":"8","author":"Mandai","year":"2020","journal-title":"Pharmacol Res Perspect"},{"issue":"5","key":"10.1007\/s13311-022-01254-3_bib44","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/s41386-018-0168-8","article-title":"TAK-071, a novel M1 positive allosteric modulator with low cooperativity, improves cognitive function in rodents with few cholinergic side effects","volume":"44","author":"Sako","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1007\/s13311-022-01254-3_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/bmjpo-2020-000731","article-title":"Multisystem comorbidities in classic Rett syndrome: a scoping review","volume":"4","author":"Fu","year":"2020","journal-title":"BMJ Paediatr Open"},{"issue":"12","key":"10.1007\/s13311-022-01254-3_bib46","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/j.1528-1167.2012.03656.x","article-title":"Epilepsy in Rett syndrome, and CDKL5- and FOXG1-gene-related encephalopathies","volume":"53","author":"Guerrini","year":"2012","journal-title":"Epilepsia"},{"issue":"2\u20133","key":"10.1007\/s13311-022-01254-3_bib47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.resp.2004.02.011","article-title":"Pontine and basal forebrain cholinergic interaction: implications for sleep and breathing","volume":"143","author":"Douglas","year":"2004","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1007\/s13311-022-01254-3_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.593554","article-title":"Loss of MeCP2 function across several neuronal populations impairs breathing response to acute hypoxia","volume":"11","author":"Ward","year":"2020","journal-title":"Front Neurol"},{"issue":"Pt 3","key":"10.1007\/s13311-022-01254-3_bib49","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1113\/jphysiol.2006.119966","article-title":"Breathing dysfunctions associated with impaired control of postinspiratory activity in Mecp2-\/y knockout mice","volume":"579","author":"Stettner","year":"2007","journal-title":"J Physiol"},{"issue":"4","key":"10.1007\/s13311-022-01254-3_bib50","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1203\/01.pdr.0000238302.84552.d0","article-title":"Autonomic nervous system dysregulation: breathing and heart rate perturbation during wakefulness in young girls with Rett syndrome","volume":"60","author":"Weese-Mayer","year":"2006","journal-title":"Pediatr Res"},{"issue":"9","key":"10.1007\/s13311-022-01254-3_bib51","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.biopsych.2015.08.018","article-title":"Chronic administration of the N-methyl-D-aspartate receptor antagonist ketamine improves Rett syndrome phenotype","volume":"79","author":"Patrizi","year":"2016","journal-title":"Biol Psychiatry"},{"issue":"40","key":"10.1007\/s13311-022-01254-3_bib52","doi-asserted-by":"crossref","first-page":"13860","DOI":"10.1523\/JNEUROSCI.2159-12.2012","article-title":"Brain activity mapping in Mecp2 mutant mice reveals functional deficits in forebrain circuits, including key nodes in the default mode network, that are reversed with ketamine treatment","volume":"32","author":"Kron","year":"2012","journal-title":"J Neurosci"},{"issue":"9","key":"10.1007\/s13311-022-01254-3_bib53","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.biopsych.2016.03.1045","article-title":"N-methyl-D-aspartate receptors, ketamine, and Rett syndrome: something special on the road to treatments?","volume":"79","author":"Katz","year":"2016","journal-title":"Biol Psychiatry"},{"issue":"45","key":"10.1007\/s13311-022-01254-3_bib54","doi-asserted-by":"crossref","first-page":"37526","DOI":"10.1074\/jbc.M502699200","article-title":"A positive feedback loop between glycogen synthase kinase 3beta and protein phosphatase 1 after stimulation of NR2B NMDA receptors in forebrain neurons","volume":"280","author":"Szatmari","year":"2005","journal-title":"J Biol Chem"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-022-01254-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-022-01254-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923010875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923010875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-022-01254-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:54:48Z","timestamp":1761807288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923010875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1878747923010875"],"URL":"https:\/\/doi.org\/10.1007\/s13311-022-01254-3","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and Preclinical Evidence for M1 Muscarinic Acetylcholine Receptor Potentiation as a Therapeutic Approach for Rett Syndrome","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-022-01254-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The authors. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}